中科信息麻醉机器人已完成 15 例临床中试，与中科院苏州纳米所合作 提升脑电波采集准确度，虽与 Neuralink 有差距，但在医疗康复应用方 面领先。 公司预估植入脑机技术的麻醉机器人市场空间为 120 亿至 200 亿元人 民币（30%渗透率），并计划拓展至康复和疼痛管理领域，目前在天府 新区万安康复医院进行试验。 国内脑机接口产品均处于临床中试阶段，尚未有产品取得正式证书，完 全商业化应用仍需时日。 中科信息麻醉机器人需完成 200 例临床中试并获国家三类医疗器械证书 方可销售，预计年底完成中试并申报，最快 2027 年下半年实现收入， 单台收费约 100 万元人民币。 受 Neuralink 量产计划及国家"十四五"规划推动，中科信息将整合中 科院资源，争取在类脑智能技术应用上率先突破，并探索向更多医疗康 复领域推广。 目前麻醉机器人采用统一收费模式，康复医院应用收费模式未定。单台 麻醉机器人费用预计 100 万元人民币，是否纳入医保尚不明确。 Q&A 中科信息在脑机接口领域的业务布局和进展如何？ 中科信息 20260105 摘要 中科信息目前在类脑智能及相关产品上的市场前景如何？ 中科信息分析认为， ...

Group 1 - China Mobile's Beijing Zhongyi Digital New Economy Industry Fund has become a shareholder in Hefei Zhongke Brain Intelligent Technology Co., Ltd. as of May 27, with registered capital increasing from approximately 14.288 million RMB to about 15.202 million RMB [1] - Hefei Zhongke Brain Intelligent Technology Co., Ltd. was established in September 2017 and focuses on intelligent control system integration, AI public data platforms, AI basic software development, intelligent robotics research, and sales of intelligent unmanned aerial vehicles [1] - The company is now jointly held by Hefei Brain Wisdom Equity Investment Partnership, Liu Haifeng, Hefei Brain Huizhi Equity Investment Partnership, and the newly added shareholder [1] Group 2 - Zhongke Brain specializes in the research and application of brain-like intelligent technology, utilizing core technologies such as computer vision, network intelligence, and cross-media multimodal analysis [1] - The company provides intelligent hybrid cloud platforms and AI solutions [1]

Core Insights - The event marked the third anniversary of the public open day at the Songshan Lake Materials Laboratory, attracting over 1,500 participants, setting a new record for public engagement in science [1] Group 1: Scientific Presentations - Two science reports were presented, including one by researcher Zou Chao on Boron Neutron Capture Therapy (BNCT), a precise cancer treatment method that targets tumor cells using boron-containing drugs [3] - Zou highlighted that BNCT is recognized as "cell-level radiotherapy," utilizing boron-10 isotopes to destroy cancer cells while protecting surrounding healthy tissue [3][5] Group 2: Public Engagement and Interaction - The event featured interactive experiments, allowing participants to engage with various scientific demonstrations, including a showcase of an electric all-terrain vehicle and demonstrations of superconductivity [6] - The public was invited to experience hands-on experiments, emphasizing the importance of engaging children in science from a young age [10] Group 3: Research and Development Focus - The open day showcased several research teams focusing on strategic basic research, industrial applications, and public technology platforms, highlighting advanced domestic equipment such as high-temperature superconducting coating devices [8] - The event included a demonstration of a scanning tunneling microscope capable of observing atoms at a scale of 0.1 nanometers, emphasizing the laboratory's commitment to cutting-edge research [8]